Corporate News     23-Jan-23
Marksans Pharma receives UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution
Marksans Pharma announced that UK MHRA has granted Market Authorisation to the Company's wholly owned subsidiary Relonchem Limited for Fluoxetine 20mg/5ml Oral Solution.

Therapeutic use of the product is for treatment of depressive illness and other mental/mood disorders.

The product will be manufactured at the plant of Bell, Sons & Co. (Druggists) located at Gifford House, Slaidburn Crescent, Southport, UK.

Previous News
  Marksans Pharma standalone net profit declines 22.22% in the September 2023 quarter
 ( Results - Announcements 09-Nov-23   14:28 )
  Marksans Pharma fixes record date for dividend
 ( Market Beat - Reports 30-May-23   17:34 )
  Marksans Pharma consolidated net profit rises 36.36% in the September 2023 quarter
 ( Results - Announcements 09-Nov-23   15:15 )
  Marksans Pharma's Goa unit concludes USFDA inspection with observations
 ( Corporate News - 18-Apr-24   11:45 )
  Marksans Pharma declines after US FDA issues Form 483 with 5 observations to Goan plant
 ( Hot Pursuit - 18-Apr-24   11:52 )
  Marksans Pharma standalone net profit rises 45.76% in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:41 )
  Marksans Pharma fixes record date for dividend
 ( Market Beat - Reports 24-May-23   17:38 )
  Marksans Pharma receives UK MHRA approval for Bells Healthcare All in One Oral Solution
 ( Corporate News - 22-Feb-22   14:05 )
  Marksans Pharma consolidated net profit rises 207.90% in the June 2017 quarter
 ( Results - Announcements 11-Aug-17   16:38 )
  Marksans Pharma receives USFDA approval for Acetaminophen ER Tablets
 ( Corporate News - 26-Aug-21   13:42 )
  Marksans Pharma announces UK MHRA nod for Bells Healthcare All in One Oral Solution
 ( Hot Pursuit - 22-Feb-22   15:15 )
Other Stories
  MMP Industries to convene board meeting
  05-Oct-24   10:23
  Mahindra & Mahindra Financial Serv. to discuss results
  05-Oct-24   10:23
  Ambey Laboratories to hold board meeting
  05-Oct-24   10:23
  Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
  05-Oct-24   10:21
  Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV
  05-Oct-24   10:19
  Just Dial announces board meeting date
  05-Oct-24   10:11
  L&T Finance schedules board meeting
  05-Oct-24   10:11
  Australian Premium Solar (India) announces board meeting date
  05-Oct-24   10:11
  Reliance Industrial InfraStructure declare Quarterly Result
  05-Oct-24   10:11
  PVV Infra to convene board meeting
  05-Oct-24   10:06
Back Top